Baricitinib plus remdesivir for hospitalized adults with Covid-19

ACTT-2 Study Group Members

Research output: Contribution to journalArticlepeer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'Baricitinib plus remdesivir for hospitalized adults with Covid-19'. Together they form a unique fingerprint.

Medicine & Life Sciences